Impact analysis of the multinational pharmaceutical industry

12.05.2016 - Health and life science

A new report by Oslo Economics and BI Norwegian Business School analyzes the impacts of the multinational pharmaceutical industry on Norway’s economy and society. The study was carried out on behalf of the American Chamber of Commerce in Norway

The aim of the report is to highlight the main ways in which the industry contributes to the Norwegian economy and society and provide comparisons with other sectors in Norway and with similar sectors in other countries. The analysis is based on official accounting data, information from in-depth interviews and data from an online questionnaire conducted in 2015.

Read the full report in English or Norwegian at AmChams website.

Stroke management in atrial fibrillation patients with rheumatoid arthritis

In collaboration with REMEDY-Centre for Treatment of Rheumatic and Musculoskeletal Diseases at Diakonhjemmet hospital, we have published an article investigating stroke management in atrial fibrillation patients with rheumatoid arthritis. The investigation relies on Norwegian registry data from hospitals and pharmacies.

Evaluation of measures in primary healthcare services

On behalf of the Norwegian Directorate of Health, Oslo Economics and the University of Oslo, in collaboration with several subject matter experts, are conducting a follow-up evaluation of measures in primary healthcare services. This year’s evaluation shows that the situation for general practitioners appears to have improved, while there are still significant challenges related to the population’s access to general medical services.

Impact analysis of the multinational pharmaceutical industry

Stroke management in atrial fibrillation patients with rheumatoid arthritis

International experiences with primary health care teams

Evaluation of measures in primary healthcare services

Bergen

Oslo

Berlin